| 2024-11-07 |
[Correspondence] A model to achieve microelimination of viral hepatitis in Shabo village, Nasarawa state, Nigeria |
Gamal Shiha, Ahmed Farahat, Ibrahim Adamu Alhassan, Ruth Bello Dalhatu Araf, Riham Soliman |
|
| 2024-11-07 |
[Clinical Picture] Pancreaticopleural fistula presenting with a massive right-sided pleural effusion after pancreatitis |
Christopher James Shephard, William Jiaen Wang, Gabriel McLachlan, Bulent Baran |
|
| 2024-11-07 |
[Comment] The surety or otherwise of leaving chronic hepatitis B untreated |
Geoffrey Dusheiko, Mzamo Mbelle |
|
| 2024-11-07 |
[Correspondence] Launch of the PANC-PALS Consortium |
Ammar A Javed, Camila Hidalgo Salinas, Christopher L Wolfgang, Marc G Besselink, PANC-PALS Consortium |
|
| 2024-11-07 |
[Editorial] Tackling obesity: drugs are only part of the solution |
The Lancet Gastroenterology & Hepatology |
|
| 2024-11-07 |
[Correspondence] Management of portal vein thrombosis in cirrhosis |
Francesco Violi, Pasquale Pignatelli |
|
| 2024-11-07 |
[Correspondence] Management of portal vein thrombosis in cirrhosis – Authors' reply |
Pierre-Emmanuel Rautou, Laure Elkrief |
|
| 2024-11-07 |
[Correspondence] Bowel cancer prevention: are we missing an opportunity? |
Colin Rees, Willie Hamilton |
|
| 2024-11-07 |
[Correspondence] Adjuvant nivolumab for gastric and gastro-oesophageal junction cancer – Authors' reply |
Mitsuro Sasako, ATTRACTION-5 authors |
|
| 2024-11-07 |
[Correspondence] Adjuvant nivolumab for gastric and gastro-oesophageal junction cancer |
Fausto Petrelli, Andrea Celotti, Lorenzo Dottorini |
|
| 2024-11-07 |
[Correspondence] GLP-1 receptor agonists and bronchial aspiration risk: what the evidence tells us |
Lorenzo Fuccio, Marianna Arvanitakis, Antonio Facciorusso |
|
| 2024-11-07 |
[Articles] Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort study |
Gibril Ndow, Yusuke Shimakawa, Damien Leith, Sulayman Bah, Rohey Bangura, Isatou Mahmoud, Lamin Bojang, Amie Ceesay, Sainabou Drammeh, Queen Bola-Lawal, Gabriel Lambert, Perrine Hardy, Patrick Ingiliz, Yazan Haddadin, Erwan Vo-Quang, Stéphane Chevaliez, G |
|
| 2024-11-07 |
[News] Research in Brief |
Holly Baker |
|
| 2024-11-07 |
[In Focus] Lucky: Learning to Live Again |
Joe Moody |
|
| 2024-11-07 |
[In Focus] A person-first podcast and the story of Alexis St Martin |
Cahal McQuillan |
|
| 2024-11-07 |
[Viewpoint] Personalisation of therapy in irritable bowel syndrome: a hypothesis |
Christopher J Black, Alexander C Ford |
|
| 2024-11-07 |
[Review] Dietary management of irritable bowel syndrome: considerations, challenges, and solutions |
Kevin Whelan, Alexander C Ford, Helen Burton-Murray, Heidi M Staudacher |
|
| 2024-11-07 |
[Articles] International expert guidance for defining and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound: a consensus statement |
Cathy Lu, Ryan Rosentreter, Claire E Parker, Julie Remillard, Stephanie R Wilson, Mark E Baker, Gauraang Bhatnagar, Jakob Begun, David H Bruining, Robert V Bryant, Britt Christensen, Brian G Feagan, Joel G Fletcher, Ilyssa Gordon, Gaylyn Henderson, Vipul |
|
| 2024-11-07 |
[News] UEG Week 2024 |
Rob Brierley |
|
| 2024-11-07 |
[Articles] Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial |
Rohit Loomba, Pierre Bedossa, Katharine Grimmer, George Kemble, Eduardo Bruno Martins, William McCulloch, Marie O'Farrell, Wen-Wei Tsai, Jose Cobiella, Eric Lawitz, Madhavi Rudraraju, Stephen A Harrison |
|
| 2024-11-07 |
[Comment] Expanding the armamentarium for metabolic dysfunction-associated steatohepatitis |
Sven M Francque, Luisa Vonghia |
|
| 2024-11-07 |
[Articles] VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study |
Man-Fung Yuen, Young-Suk Lim, Ki Tae Yoon, Tien-Huey Lim, Jeong Heo, Pisit Tangkijvanich, Won Young Tak, Vaidehi Thanawala, Daniel Cloutier, Shenghua Mao, Andre Arizpe, Andrea L Cathcart, Sneha V Gupta, Carey Hwang, Edward Gane |
|
| 2024-11-07 |
[Comment] Does siRNA-based therapy require pegylated interferon-alfa-2a to cure HBV infection? |
Fabien Zoulim |
|
| 2024-11-07 |
[Articles] Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling st |
Mathias Jachs, Aitor Odriozola, Fanny Turon, Lucile Moga, Luis Téllez, Petra Fischer, Dario Saltini, Wilhelmus J Kwanten, Maria Grasso, Elba Llop, Yuly P Mendoza, Angelo Armandi, Julia Thalhammer, Carlos Pardo, Antonio Colecchia, Federico Ravaioli, Benjam |
|
| 2024-11-07 |
[Comment] Spleen stiffness in portal hypertension algorithms: the next advance |
Cristina Rigamonti |
|
| 2024-11-07 |
[Comment] Availability of point-of-care HBV tests in resource-limited settings |
Daryl T Y Lau, Kathy Jackson, Camila A Picchio, Anna Kramvis, Mark Sonderup, Maud Lemoine, Gail Matthews, Jessica Howell, Carla S Coffin, Margaret Hellard, Alice U Lee, David A Anderson, Helene A Kerth, El Eunyoung Lee, John E Tavis, Maura Dandri, Peter A |
|
| 2024-11-07 |
[Comment] Lifting the minority tax in gastroenterology and hepatology |
Sophie M Balzora |
|
| 2024-10-10 |
[In Focus] Genius Gut |
Phoebe Ashley-Norman |
|
| 2024-10-10 |
[Editorial] Herbal and dietary supplements: unregulated hepatotoxicity |
The Lancet Gastroenterology & Hepatology |
|
| 2024-10-10 |
[News] Research in Brief |
Holly Baker |
|
| 2024-10-10 |
[Review] Sex and gender in inflammatory bowel disease outcomes and research |
Vibeke Andersen, Jessica Pingel, Heidi Lynge Søfelt, Zainab Hikmat, Mads Johansson, Vera Slyk Pedersen, Benthe Bertelsen, Anne Carlsson, Marie Lindh, Edda Svavarsdóttir, Dirk Repsilber, Maiken Thyregod Joergensen, Robin Christensen, Anja Fejrskov, Johanne |
|
| 2024-10-10 |
[In Focus] Personal Best: From Rock Bottom to the Top of the World |
Emma Starbuck |
|
| 2024-10-10 |
[Corrections] Correction to Lancet Gastroenterol Hepatol 2024; 9: 1010–19 |
|
|
| 2024-10-10 |
[Review] Disorders of gastric motility |
Andrea Shin |
|
| 2024-10-10 |
[Articles] Harms with placebo in trials of biological therapies and small molecules as induction therapy in inflammatory bowel disease: a systematic review and meta-analysis |
Shahida Din, Jonathan Segal, Jonathan Blackwell, Beatriz Gros, Christopher J Black, Alexander C Ford |
|
| 2024-10-10 |
[Comment] Do placebos harm patients in IBD trials? |
Fernando Gomollón |
|
| 2024-10-10 |
[Articles] Harms with placebo in trials of biological therapies and small molecules as maintenance therapy in inflammatory bowel disease: a systematic review and meta-analysis |
Beatriz Gros, Jonathan Blackwell, Jonathan Segal, Christopher J Black, Alexander C Ford, Shahida Din |
|
| 2024-10-10 |
[Articles] Computer-aided diagnosis for the resect-and-discard strategy for colorectal polyps: a systematic review and meta-analysis |
Cesare Hassan, Tommy Rizkala, Yuichi Mori, Marco Spadaccini, Masashi Misawa, Giulio Antonelli, Emanuele Rondonotti, Evelien Dekker, Britt B S L Houwen, Oliver Pech, Sebastian Baumer, James Weiquan Li, Daniel von Renteln, Claire Haumesser, Roberta Maselli, |
|
| 2024-10-10 |
[Comment] Is computer-aided diagnosis living up to its promise? |
Quirine E W van der Zander |
|
| 2024-10-10 |
[Comment] Global differences in the management of alcohol-associated hepatitis |
Hanna Blaney, Luis Antonio Díaz, Nhi Li, Gurpreet Malhi, Rokhsana Mortuza, Xiaolong Qi, Anand V Kulkarni, Ramon Bataller, Joaquin Cabezas, Alexandre Louvet, Elliot B Tapper, Juan Pablo Arab |
|
| 2024-10-10 |
[Articles] Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium |
Zhujun Cao, Florence Wong, Ashok K Choudhury, Patrick S Kamath, Mark Topazian, Aldo Torre, Peter C Hayes, Jacob George, Ramazan Idilman, Wai-Kay Seto, Hailemichael Desalegn, Mario Reis Alvares-da-Silva, Brian J Bush, Leroy R Thacker, Qing Xie, Jasmohan S |
|
| 2024-10-10 |
[Comment] Regional disparities of infections in cirrhosis: a call for action |
Nipun Verma, Salvatore Piano |
|
| 2024-10-10 |
[Comment] Best buy interventions to address the burden of steatotic liver disease |
Jeffrey V Lazarus, Henry E Mark, Naim Alkhouri, Luis Antonio Díaz, Ajay Duseja, C Wendy Spearman, Maja Thiele, Vincent Wai-Sun Wong, Zobair M Younossi |
|
| 2024-10-10 |
[Articles] Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial |
Matthew C Choy, Christopher F D Li Wai Suen, Danny Con, Kristy Boyd, Raquel Pena, Kathryn Burrell, Ourania Rosella, David Proud, Richard Brouwer, Alexandra Gorelik, Danny Liew, William R Connell, Emily K Wright, Kirstin M Taylor, Aviv Pudipeddi, Michelle |
|
| 2024-10-10 |
[Comment] Infliximab rescue therapy in acute severe ulcerative colitis: more does not equal better |
Saurabh Kedia, Vineet Ahuja |
|
| 2024-09-05 |
[In Focus] Nocebo, gut disorders, and diet |
Heidi M Staudacher, Leena T Putkonen |
|
| 2024-09-05 |
[Review] Natural history and progression of metabolic dysfunction-associated steatotic liver disease |
Hannes Hagström, Ying Shang, Hannes Hegmar, Patrik Nasr |
|
| 2024-09-05 |
[In Focus] Irritable bowel syndrome: an urgent issue |
Chrissie Pearson |
|
| 2024-09-05 |
[Correspondence] Prophylactic abdominal drainage after distal pancreatectomy: really unnecessary? – Author's reply |
Eduard A van Bodegraven, Alberto Balduzzi, Tess M E van Ramshorst, Giuseppe Malleo, Frederique L Vissers, Jony van Hilst, Giovanni Marchegiani, Matteo de Pastena, Roberto Salvia, Casper H J van Eijck, Marc G Besselink, Dutch Pancreatic Cancer Group |
|
| 2024-09-05 |
[News] Research in Brief |
Holly Baker |
|
| 2024-09-05 |
[Comment] Augmenting colonoscopy with AI: insights and future directions |
Sravanthi Parasa |
|
| 2024-09-05 |
[Correspondence] Prophylactic abdominal drainage after distal pancreatectomy: really unnecessary? |
Yuan Sun, Yan Li, Kezhen Zong, Ning Jiang, Baoyong Zhou |
|
| 2024-09-05 |
[Editorial] Blood tests for colorectal cancer: practical or premature? |
The Lancet Gastroenterology & Hepatology |
|
| 2024-09-05 |
[Articles] Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial |
Klara Dorman, Stefan Boeck, Karel Caca, Maximilian Reichert, Thomas J Ettrich, Helmut Oettle, Oliver Waidmann, Dominik P Modest, Lothar Müller, Patrick Michl, Stephan Kanzler, Daniel Pink, Anke Reinacher-Schick, Michael Geißler, Henning Pelz, Volker Kunzm |
|
| 2024-09-05 |
[Comment] Metastatic pancreatic cancer: a new standardised dose-reduction regimen? |
Paula Ghaneh, Daniel Palmer |
|
| 2024-09-05 |
[Articles] Polyp detection with colonoscopy assisted by the GI Genius artificial intelligence endoscopy module compared with standard colonoscopy in routine colonoscopy practice (COLO-DETECT): a multicentre, open-label, parallel-arm, pragmatic randomised |
Alexander Seager, Linda Sharp, Laura J Neilson, Andrew Brand, James S Hampton, Tom J W Lee, Rachel Evans, Luke Vale, John Whelpton, Nathania Bestwick, Colin J Rees, COLO-DETECT trial team |
|
| 2024-09-05 |
[Articles] Indocyanine green near-infrared fluorescence bowel perfusion assessment to prevent anastomotic leakage in minimally invasive colorectal surgery (AVOID): a multicentre, randomised, controlled, phase 3 trial |
Robin A Faber, Ruben P J Meijer, Daphne H M Droogh, Jasmijn J Jongbloed, Okker D Bijlstra, Fran Boersma, Jeffrey P B M Braak, Elma Meershoek-Klein Kranenbarg, Hein Putter, Fabian A Holman, J Sven D Mieog, Peter A Neijenhuis, Esther van Staveren, Johanne G |
|
| 2024-09-05 |
[Comment] The promise of indocyanine green in colorectal surgery |
Zoe Garoufalia |
|
| 2024-09-05 |
[Personal View] Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions |
Ryan J Jalleh, Chris K Rayner, Trygve Hausken, Karen L Jones, Michael Camilleri, Michael Horowitz |
|
| 2024-09-05 |
[Comment] The need for affordable, pragmatic, investigator-led clinical trials of treatment strategies in inflammatory bowel disease |
Nurulamin M Noor, Shaji Sebastian, Miles Parkes, Tim Raine |
|
| 2024-09-05 |
[Comment] Breaking down barriers between liver, addiction, and mental health services for people with alcohol-related liver disease |
Ashwin D Dhanda, Victoria Allgar, Neeraj Bhala, Lynne Callaghan, Joana Castro, Shilpa Chokshi, Amanda Clements, Colin Drummond, Ewan H Forrest, Lesle Manning, Richard Parker, Debbie L Shawcross, Jennifer Towey |
|
| 2024-08-08 |
[Correspondence] Combined tumour-infiltrating lymphocytes and microsatellite instability status as prognostic markers in colorectal cancer |
Changjing Cai, Peng Zhang, Ying Han, Hong Shen, Shan Zeng |
|
| 2024-08-08 |
[Editorial] Global progress towards alcohol harm reduction insufficient |
The Lancet Gastroenterology & Hepatology |
|
| 2024-08-08 |
[In Focus] Normothermic regional perfusion presents ethical concerns in the USA |
Bryant Furlow |
|
| 2024-08-08 |
[Correspondence] Diet or optimised medical therapy for people with irritable bowel syndrome |
Christian Lambiase, Giuseppe Chiarioni, Massimo Bellini |
|
| 2024-08-08 |
[Correspondence] Diet or optimised medical therapy for people with irritable bowel syndrome – Authors' reply |
Sanna Nybacka, Hans Törnblom, Axel Josefsson, Johann P Hreinsson, Lena Böhn, Åsa Frändemark, Cecilia Weznaver, Stine Störsrud, Magnus Simrén |
|
| 2024-08-08 |
[Comment] Expression of concern—Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis |
The Editors of The Lancet Gastroenterology & Hepatology |
|
| 2024-08-08 |
[Correspondence] Diet or optimised medical therapy for people with irritable bowel syndrome |
Alexander C Ford, Christopher J Black, Michael Camilleri |
|
| 2024-08-08 |
[Comment] Watch and wait for rectal cancer: towards data-informed surveillance |
Fahima Dossa, Martin R Weiser |
|
| 2024-08-08 |
[Comment] Optimising local treatment decisions for rectal cancer |
Krishan R Jethwa, Khush S Aujla, Aurelie Garant |
|
| 2024-08-08 |
[In Focus] A breakdown of the gut |
Genevieve Pascal |
|
| 2024-08-08 |
[News] Research in brief |
Holly Baker |
|
| 2024-08-08 |
[Correspondence] Combined tumour-infiltrating lymphocytes and microsatellite instability status as prognostic markers in colorectal cancer – Authors' reply |
Durgesh Wankhede, Michael Hoffmeister |
|
| 2024-08-08 |
[Editorial] Viral hepatitis: time for action |
The Lancet Gastroenterology & Hepatology |
|
| 2024-08-08 |
[Articles] Long-term effects of once-only flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: 21-year follow-up of the UK Flexible Sigmoidoscopy Screening randomised controlled trial |
Kate Wooldrage, Emma C Robbins, Stephen W Duffy, Amanda J Cross |
|
| 2024-08-08 |
[Comment] Brief sigmoidoscopy provides 21-year colorectal cancer risk reduction in men |
Michael Bretthauer, Nastazja D Pilonis |
|
| 2024-08-08 |
[Articles] An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial |
Oswaldo Ortiz, Maria Daca-Alvarez, Liseth Rivero-Sanchez, Antonio Z Gimeno-Garcia, Marta Carrillo-Palau, Victoria Alvarez, Alejandro Ledo-Rodriguez, Luigi Ricciardiello, Chiera Pierantoni, Robert Hüneburg, Jacob Nattermann, Raf Bisschops, Sabine Tejpar, A |
|
| 2024-08-08 |
[Comment] Artificial intelligence-assisted adenoma detection in people with Lynch syndrome |
Carol A Burke, Carole Macaron, Aparajita Singh |
|
| 2024-08-08 |
[Articles] Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021 |
GBD 2021 Appendicitis Collaborator Group |
|
| 2024-08-08 |
[News] Hepatitis C epidemic among Rohingya refugees in Cox's Bazar: a public health emergency |
Udani Samarasekera |
|
| 2024-08-08 |
[Articles] Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trial |
Eline M L van der Does de Willebois, Vittoria Bellato, Marjolijn Duijvestein, Jarmila D W van der Bilt, Koen van Dongen, Antonino Spinelli, Geert R D'Haens, Marco W Mundt, Federica Furfaro, Silvio Danese, Andrea Vignali, Willem A Bemelman, Christianne J B |
|
| 2024-08-08 |
[Comment] Targeting the mesentery with surgery in ileocolic Crohn's disease: where do we stand? |
Benjamin Click, Stefan D Holubar |
|
| 2024-08-08 |
[Review] Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies |
Laure Elkrief, Virginia Hernandez-Gea, Marco Senzolo, Agustin Albillos, Anna Baiges, Annalisa Berzigotti, Christophe Bureau, Sarwa Darwish Murad, Andrea De Gottardi, François Durand, Juan-Carlos Garcia-Pagan, Ton Lisman, Mattias Mandorfer, Valérie McLin, |
|
| 2024-08-08 |
[Review] Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision framework |
Renée Duijzer, Lucas H P Bernts, Anja Geerts, Bart van Hoek, Minneke J Coenraad, Chantal Rovers, Domenico Alvaro, Ed J Kuijper, Frederik Nevens, Jan Halbritter, Jordi Colmenero, Juozas Kupcinskas, Mahdi Salih, Marie C Hogan, Maxime Ronot, Valerie Vilgrain |
|
| 2024-07-04 |
[In Focus] Saturated Facts: the start of a preventive revolution? |
Elizabeth Haslam |
|
| 2024-07-04 |
[News] EASL Congress 2024 |
Rob Brierley |
|
| 2024-07-04 |
[Correspondence] Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial: Authors' reply |
Florentine E F Timmer, Bart Geboers, Hester J Scheffer, Anna M E Bruynzeel, Martijn R Meijerink, CROSSFIRE study investigators |
|
| 2024-07-04 |
[Correspondence] Time for a treat all approach for hepatitis B |
Rachel Halford, Danjuma Adda, Jessica Hicks, Cary James, Alexandra Smith |
|
| 2024-07-04 |
[News] Research in Brief |
Holly Baker |
|
| 2024-07-04 |
[Correspondence] Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial |
Jasmijn Maria Westerhoff, Nina Niu Sanford, William Adrian Hall |
|
| 2024-07-04 |
[News] Digestive Disease Week 2024 |
Hugh Thomas |
|
| 2024-07-04 |
[Articles] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, doubl |
Yoon-Koo Kang, Masanori Terashima, Young-Woo Kim, Narikazu Boku, Hyun Cheol Chung, Jen-Shi Chen, Jiafu Ji, Ta-Sen Yeh, Li-Tzong Chen, Min-Hee Ryu, Jong Gwang Kim, Takeshi Omori, Sun Young Rha, Tae Yong Kim, Keun Won Ryu, Shinichi Sakuramoto, Yasunori Nish |
|
| 2024-07-04 |
[Comment] Immune-checkpoint blockade in surgical management of gastric or gastro-oesophageal junction adenocarcinoma |
Maeve A Lowery |
|
| 2024-07-04 |
[Articles] Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 study |
Harry L A Janssen, Young-Suk Lim, Pietro Lampertico, Jeong Heo, Chi-Yi Chen, Claire Fournier, Tak Yin Owen Tsang, Ho Bae, Chien-Hung Chen, Carla S Coffin, Sang Hoon Ahn, Huy Trinh, John F Flaherty, Frida Abramov, Yang Zhao, Yang Liu, Audrey Lau, Polina Ge |
|
| 2024-07-04 |
[Comment] Broadening clinical indications of tenofovir alafenamide in chronic hepatitis B |
Lung-Yi Mak |
|
| 2024-07-04 |
[Editorial] No accident: the UK infected blood scandal |
The Lancet Gastroenterology & Hepatology |
|
| 2024-07-04 |
[Articles] Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open- |
Arndt Vogel, Anna Saborowski, Patrick Wenzel, Henning Wege, Gunnar Folprecht, Albrecht Kretzschmar, Philipp Schütt, Lutz Jacobasch, Nicolas Ziegenhagen, Stefan Boeck, Danmei Zhang, Stephan Kanzler, Sebastian Belle, Johannes Mohm, Eray Gökkurt, Christian L |
|
| 2024-07-04 |
[Comment] Nanoliposomal irinotecan in advanced biliary tract cancers |
David Malka, Raphaël Colle |
|
| 2024-07-04 |
[Comment] Considerations for treating autistic individuals in gastroenterology clinics |
Timothy Buie, Kara Margolis |
|
| 2024-07-04 |
[Articles] Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study |
Do-Youn Oh, Aiwu Ruth He, Mohamed Bouattour, Takuji Okusaka, Shukui Qin, Li-Tzong Chen, Masayuki Kitano, Choong-kun Lee, Jin Won Kim, Ming-Huang Chen, Thatthan Suksombooncharoen, Masafumi Ikeda, Myung Ah Lee, Jen-Shi Chen, Piotr Potemski, Howard A Burris, |
|
